News

Australian primary healthcare professionals are a step closer to having an evidence-based guide to safer prescribing – designed to reduce medication harm and ease burden on the national healthcare system.

With pharmacists taking on expanded roles in areas like prescribing and aged care, it’s important as students that our education at Monash keeps pace with these changes and prepares us for the realities of practice.

Bachelor of Pharmaceutical Science students teamed up directly with the Bachelor of Design students in a dedicated co-design studio at Monash University.

This project represents a true shift in neuro-oncology, moving away from trying to disrupt the barrier and instead working with the brain's own biology to ferry drugs across safely.

Researchers from CMUS at MIPS evaluated strategies through a major multi-state trial called EMBRACE. To shift staff behaviour, the trial deployed multiple approaches, rather than simply distributing a manual.

CREATE and MIPS will jointly advance targeted Chimeric Antigen Receptor (CAR) therapy, with the goal of enabling precise, cell-type-specific in vivo delivery of CAR payloads.

HTX could allow Monash to screen a library of ~1,000 compounds automatically in three days without human intervention, which is well beyond what is currently feasible with manual data collection.

Combining Monash’s research expertise with the TGA’s regulatory leadership, we can advance innovation while also creating meaningful opportunities for student engagement and exposure to real-world regulatory challenges

Victorian model for oral self-administration of voluntary assisted dying (VAD) medication is safe and effective, providing the largest global experience of patient outcomes.